Introduction: Sporotrichosis is a rare fungal infection in transplant patients; among these patients, it occurs mostly in renal transplant patients. Sporothrix schenkii is the primary pathogen responsible. A high index of suspicion is required to make the diagnosis keeping important differential diagnoses in mind. History of trauma through recreational or occupational exposure to the fungus may assist in making the diagnosis. Treatment is difficult, with long-term use of potentially nephrotoxic and cytochrome P450 inhibitor antifungal agents leading to potential calcineurin inhibitors toxicity. We describe two renal transplant patients presenting with distinct sporotrichosis infection: "Case 2" being only the second reported case ever of meningeal sporotrichosis. We subsequently review the general aspects of sporotrichosis, specifically in renal transplant patients as described in the medical literature. Case presentation: Case 1, a 43-year-old mixed ancestry male patient presented with a non-healing ulcer on the left arm for 1 year, he was diagnosed with cutaneous sporotrichosis and was successfully treated with itraconazole monotherapy. Case 2, a 56-year-old mixed ancestry male patient presented with a slow decline in functions, confusion, inappropriate behavior, rigors and significant loss of weight and appetite over the past 4 months, he was diagnosed with meningeal sporotrichosis and was successfully treated with a combination of deoxycholate amphotericin B and itraconazole. Conclusion: Physicians taking care of renal transplant patients should have a high index of suspicion for sporotrichosis infection particularly when conventional therapy for common conditions fails. Susceptibility testing is recommended to identify the most effective antifungal agent and its dose. The slow nature of growth of Sporothrix schenkii necessitates patients to be on amphotericin B until the time results are available. Finally, there is a need to be aware of potential drug-drug interactions of the azoles with calcineurin inhibitors and the required dose adjustments to prevent therapy related adverse events.
We present an iatrogenic, pleuro-pericardial connection resulting from pericardiocentesis of a large, tuberculous, pericardial effusion. Recognition of this situation is paramount when one is unable to aspirate pericardial fluid after a successful, initial puncture. Such knowledge will help prevent myocardial or coronary artery injury with further attempts at aspiration.
Accurate estimates of left ventricle elastances based on non-invasive measurements are required for clinical decision-making during treatment of valvular diseases. The present study proposes a parameter discovery approach based on a lumped parameter model of the cardiovascular system in conjunction with optimization and non-invasive, clinical input measurements to approximate important cardiac parameters, including left ventricle elastances. Important parameters pertaining to ventricular function was estimated using gradient optimisation. Forward-mode automatic differentiation was used to estimate the Jacobian matrices and compared to the common finite differences approach. Synthetic data of healthy and diseased hearts were generated as proxies for non-invasive clinical measurements and used to evaluate the algorithm. Twelve parameters including left ventricle elastances were selected for optimization based on 99% explained variation in mean left ventricle pressure and volume. The hybrid optimization strategy yielded the best overall results compared to 1st order optimization with automatic differentiation and finite difference approaches, with mean absolute percentage errors ranging from 6.67% to 14.14%. Errors in left ventricle elastance estimates for simulated aortic stenosis and mitral regurgitation were smallest when including synthetic measurements for arterial pressure and valvular flow rate at approximately 2% and degraded to roughly 5% when including volume trends as well. However, the latter resulted in better tracking of the left ventricle pressure waveforms and may be considered when the necessary equipment is available.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.